Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium add-on to personalized maintenance ECT after successful ECT for depression
NL-OMON49873Not yet recruiting
- Sponsor
- University of Antwerp
- Start
- Jan 2021
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of lithium in major depressive disorder (MDD) (2 arms), sponsored by University of Antwerp. Primary endpoint: Improvement of prevention of relapse by 20%. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
lithium
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON49873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49873.